Anumana, an nference venture, Receives FDA 510(k) Clearance on ECG-AI LEF for Early Detection of Low EF
< Back to All News
FDA Grants Breakthrough Device Designation to Anumana’s ECG Pulmonary Hypertension Early Detection AI Algorithm
Featuring key corporate highlights and an overview of nference’s technology
@2023 nference, Inc. All rights reserved.